دورية أكاديمية

Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.

التفاصيل البيبلوغرافية
العنوان: Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.
المؤلفون: Gao, Guangyi, Gajewski, Byron J., Wick, Jo, Beall, Jonathan, Saver, Jeffrey L., Meinzer, Caitlyn, the STEP-STONE Executive Committee, Derdeyn, Colin, Fiorella, David, Jovin, Tudor, Khatri, Pooja, Mistry, Eva, Mocco, J., Nogueira, Raul, Siddiqui, Adnan, STEP-STONE Executive Committee
المصدر: Trials; 9/6/2022, Vol. 23 Issue 1, p1-15, 15p, 2 Diagrams, 3 Charts, 7 Graphs
مستخلص: Background: Platform trials are well-known for their ability to investigate multiple arms on heterogeneous patient populations and their flexibility to add/drop treatment arms due to efficacy/lack of efficacy. Because of their complexity, it is important to develop highly optimized, transparent, and rigorous designs that are cost-efficient, offer high statistical power, maximize patient benefit, and are robust to changes over time.Methods: To address these needs, we present a Bayesian platform trial design based on a beta-binomial model for binary outcomes that uses three key strategies: (1) hierarchical modeling of subgroups within treatment arms that allows for borrowing of information across subgroups, (2) utilization of response-adaptive randomization (RAR) schemes that seek a tradeoff between statistical power and patient benefit, and (3) adjustment for potential drift over time. Motivated by a proposed clinical trial that aims to find the appropriate treatment for different subgroup populations of ischemic stroke patients, extensive simulation studies were performed to validate the approach, compare different allocation rules, and study the model operating characteristics.Results and Conclusions: Our proposed approach achieved high statistical power and good patient benefit and was also robust against population drift over time. Our design provided a good balance between the strengths of both the traditional RAR scheme and fixed 1:1 allocation and may be a promising choice for dichotomous outcomes trials investigating multiple subgroups. [ABSTRACT FROM AUTHOR]
Copyright of Trials is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17456215
DOI:10.1186/s13063-022-06664-4